64 results
8-K
EX-10.1
ORIC
ORIC Pharmaceuticals Inc
29 Mar 24
Departure of Directors or Certain Officers
4:15pm
on the date that a majority of members of the Board is replaced during any twelve (12) month period by Directors whose appointment or election … is not endorsed by a majority of the members of the Board prior to the date of the appointment or election. For purposes of this subsection (ii), if any Person
S-3ASR
EX-4.2
ORIC
ORIC Pharmaceuticals Inc
11 Mar 24
Automatic shelf registration
5:28pm
of a majority in principal amount of the outstanding Securities of that Series, by written notice to the Company and the Trustee, may rescind and annul … by the Holders of a majority in principal amount of the outstanding Securities of that Series;
it being understood, intended and expressly covenanted
S-3ASR
ORIC
ORIC Pharmaceuticals Inc
11 Mar 24
Automatic shelf registration
5:28pm
action on the part of the trustee or any holder.
The holders of a majority in principal amount of the outstanding debt securities of an affected series … any loss, liability or expense. The holders of a majority in principal amount of the outstanding debt securities of any series will have the right
8-K
EX-10.1
vq24z
22 Jan 24
ORIC Pharmaceuticals Announces $125 Million Private Placement Financing
9:01am
8-K
EX-99.1
j5e0kqv8bw qce
11 Dec 23
Other Events
4:05pm
8-K
EX-10.1
v5t8m52xv7m
27 Jun 23
ORIC Pharmaceuticals Announces $85 Million Private Placement Financing
6:05am
424B5
tbfn94o7y4b
21 Dec 22
Prospectus supplement for primary offering
5:23pm
SC TO-I
EX-99
avu3dcedkmq2hy
21 Jun 22
Issuer tender offer statement
4:06pm
POS AM
j3a89y6
22 Mar 22
Prospectus update (post-effective amendment)
4:07pm